{
  "abstract": "Background Fibrinogenase for injection is an effective antithrombotic agent for eligible patients with acute ischaemic stroke (AIS), but evidence regarding its treatment effects remains limited. This study aimed to evaluate the efficacy and safety of fibrinogenase for injection in patients with AIS who did not receive reperfusion therapies.Methods A multicentre, randomised, double-blind, placebo-controlled clinical trial was conducted at 12 hospitals in China. Inclusion criteria comprised patients aged 18–85 years with a diagnosis of AIS, an NIH Stroke Scale (NIHSS) score of 4 to 25 and within 72 hours of symptom onset. Eligible patients were randomly allocated in a 1:1 ratio to receive fibrinogenase for injection or placebo. The primary efficacy endpoint was the modified Rankin Scale (mRS) Score at 90 days after randomisation.Results Among 235 patients with AIS who were randomised, 233 were included in the intention-to-treat population (117 in the fibrinogenase for injection group and 116 in the placebo group). The mRS score at 90 days after randomisation was significantly lower in the fibrinogenase group (1 (0–2)) than in the placebo group (2 (1–3)), with a favourable shift in the distribution of mRS scores (OR 2.38, 95% CI 1.49 to 3.85; p<0.001). A significantly lower median NIHSS score at 90 days was observed in the fibrinogenase group (1 (0–2)) compared with the placebo group (2 (1–4)) (OR 1.95, 95% CI 1.23 to 3.10; p<0.001). The incidence of haemorrhagic events and mortality during treatment was comparable between the two groups.Conclusions In patients with AIS, treatment with fibrinogenase for injection was associated with improved 90-day functional outcomes compared with placebo. This clinical benefit was particularly evident among those who were randomised within 48 hours of symptom onset and in those with mild to moderate stroke due to large artery atherosclerosis or small artery occlusion.Trial registration number ChiCTR2100042526; Chinese Clinical Trial Registry.",
  "authors": [
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Mengmeng Ma"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Jinghuan Fang"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Xin Jiang"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Qian Liu"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China",
        "Department of Neurology, West China Tianfu Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Jian Guo"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Ning Chen"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Yang Zhang"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Yanbo Li"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Changling Li"
    },
    {
      "affiliations": [
        "Department of Neurology, Xuanhan County People’s Hospital, Dazhou, Sichuan, China"
      ],
      "name": "Rujiang Zhou"
    },
    {
      "affiliations": [
        "Department of Neurology, The First People’s Hospital of Yibin, Yibin, Sichuan, China"
      ],
      "name": "Hao Li"
    },
    {
      "affiliations": [
        "Department of Neurology, Suining Central Hospital, Suining, Sichuan, China"
      ],
      "name": "Ming Yu"
    },
    {
      "affiliations": [
        "Department of Neurology, The People's Hospital of Leshan, Leshan, Sichuan, China"
      ],
      "name": "Wei Yuan"
    },
    {
      "affiliations": [
        "Department of Neurology, Chengdu Pidu District People's Hospital, Chengdu, Sichuan, China"
      ],
      "name": "Yi Xiong"
    },
    {
      "affiliations": [
        "Department of Neurology, University Medical Center Erlangen-Nuremberg, Erlangen, Germany"
      ],
      "name": "Stefan Schwab"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Muke Zhou"
    },
    {
      "affiliations": [
        "Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China",
        "Department of Neurology, West China Tianfu Hospital of Sichuan University, Chengdu, Sichuan, China"
      ],
      "name": "Li He"
    }
  ],
  "title": "Fibrinogenase for injection in the treatment of acute ischaemic stroke: a randomised clinical trial",
  "uid": "73371f8c-cb32-5240-b6e2-6755428915c7"
}